Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: A report from the National Down Syndrome Project

American Journal of Medical Genetics, Part A

Volumn 161, Issue 3, 2013, Pages 438-444

  Hollis, Natasha D ^a   Allen, Emily G ^a   Oliver, Tiffany Renee ^a,h   Tinker, Stuart W ^a   Druschel, Charlotte ^b   Hobbs, Charlotte A ^c   O'Leary, Leslie A ^d   Romitti, Paul A ^e   Royle, Marjorie H ^f   Torfs, Claudine P ^g   Freeman, Sallie B ^a   Sherman, Stephanie L ^a   Bean, Lora J H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^g PUBLIC HEALTH INSTITUTE   (United States)

^h SPELMAN COLLEGE   (United States)

Author keywords

Aneuploidy; Chromosome segregation; Down syndrome; Folic acid; Meiosis; Nondisjunction; Trisomy 21

Indexed keywords

FOLIC ACID;

ADULT; AGING; ARTICLE; CHROMOSOME 21; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; MATERNAL AGE; MATERNAL BEHAVIOR; MEIOSIS; NONDISJUNCTION; OOCYTE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; TRISOMY 21;

ADULT; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 21; DIETARY SUPPLEMENTS; DOWN SYNDROME; FEMALE; FOLIC ACID; HUMANS; INFANT; MEIOSIS; NONDISJUNCTION, GENETIC; PRECONCEPTION CARE; RISK;

EID: 84874199516     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35796     Document Type: Article

References (36)

1. Allen EG, Freeman SB, Druschel C, Hobbs CA, O'Leary LA, Romitti PA, Royle MH, Torfs CP, Sherman SL. 2009. Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: A report from the Atlanta and National Down Syndrome Projects. Hum Genet 125: 41-52.
2. Antonarakis SE, Petersen MB, McInnis MG, Adelsberger PA, Schinzel AA, Binkert F, Pangalos C, Raoul O, Slaugenhaupt SA, Hafez M, et al. 1992. The meiotic stage of nondisjunction in trisomy 21: Determination by using DNA polymorphisms. Am J Hum Genet 50: 544-550.
3. Bernstein BE, Meissner A, Lander ES. 2007. The mammalian epigenome. Cell 128: 669-681.
4. Blackburn S. 2007. Maternal, fetal, & neonatal physiology: A clinical perspective. St. Louis: Saunders. 777 p.
5. Botto LD, Mulinare J, Yang Q, Liu Y, Erickson JD. 2004. Autosomal trisomy and maternal use of multivitamin supplements. Am J Med Genet Part A 125A: 113-116.
6. Canfield MA, Collins JS, Botto LD, Williams LJ, Mai CT, Kirby RS, Pearson K, Devine O, Mulinare J. 2005. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: Findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol 73: 679-689.
7. CDC. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 41: 1-7.
8. Chiang T, Duncan FE, Schindler K, Schultz RM, Lampson MA. 2010. Evidence that weakened centromere cohesion is a leading cause of age-related aneuploidy in oocytes. Curr Biol 20: 1522-1528.
9. Christianson RE, Sherman SL, Torfs CP. 2004. Maternal meiosis II nondisjunction in trisomy 21 is associated with maternal low socioeconomic status. Genet Med 6: 487-494.
10. Collins JS, Olson RL, DuPont BR, Wolff DJ, Best RG, Stevenson RE. 2002. Prevalence of aneuploidies in South Carolina in the 1990s. Genet Med 4: 131-135.
11. Coppede F. 2009. The complex relationship between folate/homocysteine metabolism and risk of Down syndrome. Mutat Res 682: 54-70.
12. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327: 1832-1835.
13. Czeizel AE, Puho E. 2005. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: Case-control study. Nutrition 21: 698-704; discussion 774.
14. Freeman SB, Allen EG, Oxford-Wright CL, Tinker SW, Druschel C, Hobbs CA, O'Leary LA, Romitti PA, Royle MH, Torfs CP, Sherman SL. 2007. The National Down Syndrome Project: Design and implementation. Public Health Rep 122: 62-72.
15. Ghosh S, Feingold E, Dey SK. 2009. Etiology of Down syndrome: Evidence for consistent association among altered meiotic recombination, nondisjunction, and maternal age across populations. Am J Med Genet Part A 149A: 1415-1420.
16. Ghosh S, Feingold E, Chakraborty S, Dey SK. 2010. Telomere length is associated with types of chromosome 21 nondisjunction: A new insight into the maternal age effect on Down syndrome birth. Hum Genet 127: 403-409.
17. Gomez D, Solsona E, Guitart M, Baena N, Gabau E, Egozcue J, Caballin M, Mrosovsky N. 2000. Origin of trisomy 21 in Down syndrome cases from a Spanish population registry. Ann Genet 43: 23-28.
18. Hassold TJ, Jacobs PA. 1984. Trisomy in man. Annu Rev Genet 18: 69-97.
19. Hodges CA, Revenkova E, Jessberger R, Hassold TJ, Hunt PA. 2005. SMC1beta-deficient female mice provide evidence that cohesins are a missing link in age-related nondisjunction. Nat Genet 37: 1351-1355.
20. James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW. 1999. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70: 495-501.
21. Kitajima TS, Yokobayashi S, Yamamoto M, Watanabe Y. 2003. Distinct cohesin complexes organize meiotic chromosome domains. Science 300: 1152-1155.
22. Lamb NE, Sherman SL, Hassold TJ. 2005a. Effect of meiotic recombination on the production of aneuploid gametes in humans. Cytogenet Genome Res 111: 250-255.
23. Lamb NE, Yu K, Shaffer J, Feingold E, Sherman SL. 2005b. Association between maternal age and meiotic recombination for trisomy 21. Am J Hum Genet 76: 91-99.
24. Mikkelsen M, Hallberg A, Poulsen H, Frantzen M, Hansen J, Petersen M. 1995. Epidemiology study of Down's syndrome in Denmark, including family studies of chromosomes and DNA markers. Develop Brain Dysfunct 8: 4-12.
25. Mutton D, Alberman E, Hook EB. 1996. Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists. J Med Genet 33: 387-394.
26. Nagaoka SI, Hassold TJ, Hunt PA. 2012. Human aneuploidy: Mechanisms and new insights into an age-old problem. Nat Rev Genet 13: 493-504.
27. Oliver TR, Feingold E, Yu K, Cheung V, Tinker S, Yadav-Shah M, Masse N, Sherman SL. 2008. New insights into human nondisjunction of chromosome 21 in oocytes. PLoS Genet 4: e1000033.
28. Oliver TR, Tinker SW, Allen EG, Hollis N, Locke AE, Bean LJ, Chowdhury R, Begum F, Marazita M, Cheung V, Feingold E, Sherman SL. 2011. Altered patterns of multiple recombinant events are associated with nondisjunction of chromosome 21. Hum Genet. 131: 1039-46.
29. Ray JG, Meier C, Vermeulen MJ, Cole DE, Wyatt PR. 2003. Prevalence of trisomy 21 following folic acid food fortification. Am J Med Genet Part A 120A: 309-313.
30. Simmons CJ, Mosley BS, Fulton-Bond CA, Hobbs CA. 2004. Birth defects in Arkansas: Is folic acid fortification making a difference? Birth Defects Res A Clin Mol Teratol 70: 559-564.
31. Tachibana-Konwalski K, Godwin J, van der Weyden L, Champion L, Kudo NR, Adams DJ, Nasmyth K. 2010. Rec8-containing cohesin maintains bivalents without turnover during the growing phase of mouse oocytes. Genes Dev 24: 2505-2516.
32. Wald NJ, Sneddon J. 1991. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338: 131-137.
33. Watanabe Y. 2012. Geometry and force behind kinetochore orientation: Lessons from meiosis. Nat Rev Mol Cell Biol 13: 370-382.
34. Yang Q, Sherman SL, Hassold TJ, Allran K, Taft L, Pettay D, Khoury MJ, Erickson JD, Freeman SB. 1999. Risk factors for trisomy 21: Maternal cigarette smoking and oral contraceptive use in a population-based case-control study. Genet Med 1: 80-88.
35. Yang QH, Carter HK, Mulinare J, Berry RJ, Friedman JM, Erickson JD. 2007. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: Findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr 85: 1409-1416.
36. Yoon PW, Freeman SB, Sherman SL, Taft LF, Gu Y, Pettay D, Flanders WD, Khoury MJ, Hassold TJ. 1996. Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: A population-based study. Am J Hum Genet 58: 628-633.